Baidu
map
INDIAN J MED RES 润色咨询

INDIAN JOURNAL OF MEDICAL RESEARCH

出版年份:暂无数据 年文章数:1846 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:5.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1184891, encodeId=e76711848917a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:感染病<br>经验分享:2021年11月投稿,状态一直是Under Process,大家知道怎么回事吗?是少上传东西吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Sun Jan 16 17:09:28 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091869, encodeId=6ad91091869b4, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091870, encodeId=e79010918e010, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590602, encodeId=137d590602ef, content=中了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b135323206, createdName=148b23fcm35暂无昵称, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569481, encodeId=a5ef56948179, content=怎么样,录用了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d822101599, createdName=huanghehh, createdTime=Sat Apr 13 00:00:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564654, encodeId=bb775646549c, content=投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Wed Dec 19 17:22:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542140, encodeId=5784542140e8, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506848, encodeId=88fd50684812, content=这杂志需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 16 11:13:00 CST 2014, time=2014-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499192, encodeId=ee4e49919291, content=慢,初审5个月没消息!拒稿率高的惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=453, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 04 10:14:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498200, encodeId=67cc49820045, content=Acceptance rate for 2013 3%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 01 17:50:00 CST 2013, time=2013-08-01, status=1, ipAttribution=)]
    2022-01-16 呆子550

    审稿速度:2.0 | 投稿命中率:25.0
    偏重的研究方向:感染病
    经验分享:2021年11月投稿,状态一直是Under Process,大家知道怎么回事吗?是少上传东西吗?

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1184891, encodeId=e76711848917a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:感染病<br>经验分享:2021年11月投稿,状态一直是Under Process,大家知道怎么回事吗?是少上传东西吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Sun Jan 16 17:09:28 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091869, encodeId=6ad91091869b4, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091870, encodeId=e79010918e010, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590602, encodeId=137d590602ef, content=中了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b135323206, createdName=148b23fcm35暂无昵称, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569481, encodeId=a5ef56948179, content=怎么样,录用了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d822101599, createdName=huanghehh, createdTime=Sat Apr 13 00:00:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564654, encodeId=bb775646549c, content=投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Wed Dec 19 17:22:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542140, encodeId=5784542140e8, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506848, encodeId=88fd50684812, content=这杂志需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 16 11:13:00 CST 2014, time=2014-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499192, encodeId=ee4e49919291, content=慢,初审5个月没消息!拒稿率高的惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=453, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 04 10:14:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498200, encodeId=67cc49820045, content=Acceptance rate for 2013 3%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 01 17:50:00 CST 2013, time=2013-08-01, status=1, ipAttribution=)]
    2021-12-28 MS68862005

    期刊的审稿时间一般是多久?

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1184891, encodeId=e76711848917a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:感染病<br>经验分享:2021年11月投稿,状态一直是Under Process,大家知道怎么回事吗?是少上传东西吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Sun Jan 16 17:09:28 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091869, encodeId=6ad91091869b4, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091870, encodeId=e79010918e010, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590602, encodeId=137d590602ef, content=中了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b135323206, createdName=148b23fcm35暂无昵称, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569481, encodeId=a5ef56948179, content=怎么样,录用了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d822101599, createdName=huanghehh, createdTime=Sat Apr 13 00:00:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564654, encodeId=bb775646549c, content=投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Wed Dec 19 17:22:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542140, encodeId=5784542140e8, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506848, encodeId=88fd50684812, content=这杂志需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 16 11:13:00 CST 2014, time=2014-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499192, encodeId=ee4e49919291, content=慢,初审5个月没消息!拒稿率高的惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=453, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 04 10:14:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498200, encodeId=67cc49820045, content=Acceptance rate for 2013 3%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 01 17:50:00 CST 2013, time=2013-08-01, status=1, ipAttribution=)]
    2021-12-29 小动量

    期刊给我发了一封信,但我看不懂怎么办?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1184891, encodeId=e76711848917a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:感染病<br>经验分享:2021年11月投稿,状态一直是Under Process,大家知道怎么回事吗?是少上传东西吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Sun Jan 16 17:09:28 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091869, encodeId=6ad91091869b4, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091870, encodeId=e79010918e010, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590602, encodeId=137d590602ef, content=中了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b135323206, createdName=148b23fcm35暂无昵称, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569481, encodeId=a5ef56948179, content=怎么样,录用了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d822101599, createdName=huanghehh, createdTime=Sat Apr 13 00:00:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564654, encodeId=bb775646549c, content=投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Wed Dec 19 17:22:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542140, encodeId=5784542140e8, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506848, encodeId=88fd50684812, content=这杂志需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 16 11:13:00 CST 2014, time=2014-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499192, encodeId=ee4e49919291, content=慢,初审5个月没消息!拒稿率高的惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=453, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 04 10:14:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498200, encodeId=67cc49820045, content=Acceptance rate for 2013 3%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 01 17:50:00 CST 2013, time=2013-08-01, status=1, ipAttribution=)]
    2020-05-10 148b23fcm35暂无昵称

    中了吗oncology2005 2018-12-19 17:22:00 发表:
    投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。

    oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1184891, encodeId=e76711848917a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:感染病<br>经验分享:2021年11月投稿,状态一直是Under Process,大家知道怎么回事吗?是少上传东西吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Sun Jan 16 17:09:28 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091869, encodeId=6ad91091869b4, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091870, encodeId=e79010918e010, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590602, encodeId=137d590602ef, content=中了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b135323206, createdName=148b23fcm35暂无昵称, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569481, encodeId=a5ef56948179, content=怎么样,录用了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d822101599, createdName=huanghehh, createdTime=Sat Apr 13 00:00:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564654, encodeId=bb775646549c, content=投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Wed Dec 19 17:22:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542140, encodeId=5784542140e8, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506848, encodeId=88fd50684812, content=这杂志需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 16 11:13:00 CST 2014, time=2014-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499192, encodeId=ee4e49919291, content=慢,初审5个月没消息!拒稿率高的惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=453, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 04 10:14:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498200, encodeId=67cc49820045, content=Acceptance rate for 2013 3%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 01 17:50:00 CST 2013, time=2013-08-01, status=1, ipAttribution=)]
    2019-04-13 huanghehh

    怎么样,录用了吗oncology2005 2018-12-19 17:22:00 发表:
    投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。

    oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1184891, encodeId=e76711848917a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:感染病<br>经验分享:2021年11月投稿,状态一直是Under Process,大家知道怎么回事吗?是少上传东西吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Sun Jan 16 17:09:28 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091869, encodeId=6ad91091869b4, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091870, encodeId=e79010918e010, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590602, encodeId=137d590602ef, content=中了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b135323206, createdName=148b23fcm35暂无昵称, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569481, encodeId=a5ef56948179, content=怎么样,录用了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d822101599, createdName=huanghehh, createdTime=Sat Apr 13 00:00:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564654, encodeId=bb775646549c, content=投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Wed Dec 19 17:22:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542140, encodeId=5784542140e8, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506848, encodeId=88fd50684812, content=这杂志需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 16 11:13:00 CST 2014, time=2014-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499192, encodeId=ee4e49919291, content=慢,初审5个月没消息!拒稿率高的惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=453, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 04 10:14:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498200, encodeId=67cc49820045, content=Acceptance rate for 2013 3%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 01 17:50:00 CST 2013, time=2013-08-01, status=1, ipAttribution=)]
    2018-12-19 oncology2005

    投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1184891, encodeId=e76711848917a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:感染病<br>经验分享:2021年11月投稿,状态一直是Under Process,大家知道怎么回事吗?是少上传东西吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Sun Jan 16 17:09:28 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091869, encodeId=6ad91091869b4, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091870, encodeId=e79010918e010, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590602, encodeId=137d590602ef, content=中了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b135323206, createdName=148b23fcm35暂无昵称, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569481, encodeId=a5ef56948179, content=怎么样,录用了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d822101599, createdName=huanghehh, createdTime=Sat Apr 13 00:00:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564654, encodeId=bb775646549c, content=投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Wed Dec 19 17:22:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542140, encodeId=5784542140e8, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506848, encodeId=88fd50684812, content=这杂志需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 16 11:13:00 CST 2014, time=2014-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499192, encodeId=ee4e49919291, content=慢,初审5个月没消息!拒稿率高的惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=453, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 04 10:14:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498200, encodeId=67cc49820045, content=Acceptance rate for 2013 3%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 01 17:50:00 CST 2013, time=2013-08-01, status=1, ipAttribution=)]
    2017-07-14 qiqi

    从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1184891, encodeId=e76711848917a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:感染病<br>经验分享:2021年11月投稿,状态一直是Under Process,大家知道怎么回事吗?是少上传东西吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Sun Jan 16 17:09:28 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091869, encodeId=6ad91091869b4, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091870, encodeId=e79010918e010, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590602, encodeId=137d590602ef, content=中了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b135323206, createdName=148b23fcm35暂无昵称, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569481, encodeId=a5ef56948179, content=怎么样,录用了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d822101599, createdName=huanghehh, createdTime=Sat Apr 13 00:00:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564654, encodeId=bb775646549c, content=投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Wed Dec 19 17:22:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542140, encodeId=5784542140e8, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506848, encodeId=88fd50684812, content=这杂志需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 16 11:13:00 CST 2014, time=2014-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499192, encodeId=ee4e49919291, content=慢,初审5个月没消息!拒稿率高的惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=453, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 04 10:14:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498200, encodeId=67cc49820045, content=Acceptance rate for 2013 3%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 01 17:50:00 CST 2013, time=2013-08-01, status=1, ipAttribution=)]
    2014-10-16 匿名用户

    这杂志需要版面费吗?

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1184891, encodeId=e76711848917a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:感染病<br>经验分享:2021年11月投稿,状态一直是Under Process,大家知道怎么回事吗?是少上传东西吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Sun Jan 16 17:09:28 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091869, encodeId=6ad91091869b4, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091870, encodeId=e79010918e010, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590602, encodeId=137d590602ef, content=中了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b135323206, createdName=148b23fcm35暂无昵称, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569481, encodeId=a5ef56948179, content=怎么样,录用了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d822101599, createdName=huanghehh, createdTime=Sat Apr 13 00:00:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564654, encodeId=bb775646549c, content=投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Wed Dec 19 17:22:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542140, encodeId=5784542140e8, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506848, encodeId=88fd50684812, content=这杂志需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 16 11:13:00 CST 2014, time=2014-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499192, encodeId=ee4e49919291, content=慢,初审5个月没消息!拒稿率高的惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=453, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 04 10:14:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498200, encodeId=67cc49820045, content=Acceptance rate for 2013 3%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 01 17:50:00 CST 2013, time=2013-08-01, status=1, ipAttribution=)]
    2013-10-04 匿名用户

    慢,初审5个月没消息!拒稿率高的惊人!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1184891, encodeId=e76711848917a, content=审稿速度:2.0 | 投稿命中率:25.0<br>偏重的研究方向:感染病<br>经验分享:2021年11月投稿,状态一直是Under Process,大家知道怎么回事吗?是少上传东西吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2361732147, createdName=呆子550, createdTime=Sun Jan 16 17:09:28 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091869, encodeId=6ad91091869b4, content=期刊的审稿时间一般是多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091870, encodeId=e79010918e010, content=期刊给我发了一封信,但我看不懂怎么办?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590602, encodeId=137d590602ef, content=中了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b135323206, createdName=148b23fcm35暂无昵称, createdTime=Sun May 10 00:00:00 CST 2020, time=2020-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569481, encodeId=a5ef56948179, content=怎么样,录用了吗<span class="quote">oncology2005 2018-12-19 17:22:00 发表:<br>投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。</span>, beContent=oncology2005 2018-12-19 17:22:00 发表: 投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d822101599, createdName=huanghehh, createdTime=Sat Apr 13 00:00:00 CST 2019, time=2019-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564654, encodeId=bb775646549c, content=投了1个月,昨天收到 邮件要求有医学伦理委员会的证明文件(需要英文版),也没有提出修改意见,盼高人指点一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0581560681, createdName=oncology2005, createdTime=Wed Dec 19 17:22:00 CST 2018, time=2018-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542140, encodeId=5784542140e8, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=416, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506848, encodeId=88fd50684812, content=这杂志需要版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Oct 16 11:13:00 CST 2014, time=2014-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499192, encodeId=ee4e49919291, content=慢,初审5个月没消息!拒稿率高的惊人!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=453, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Oct 04 10:14:00 CST 2013, time=2013-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=498200, encodeId=67cc49820045, content=Acceptance rate for 2013 3%, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=451, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Aug 01 17:50:00 CST 2013, time=2013-08-01, status=1, ipAttribution=)]
    2013-08-01 匿名用户

    Acceptance rate for 2013 3%

    0

共20条页码: 1/2页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map